Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease

Abstract

MOG-ab identify a subgroup of adult patients with NMO, LETM and ON that have better outcome than those associated with AQP4-ab. MOG-ab are more frequently detected in serum than CSF and the follow-up of titres does not correlate with outcome.